This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

BenzingaDec 16 21:17

JonesTrading Initiates Alto Neuroscience(ANRO.US) With Buy Rating, Announces Target Price $18

Futu NewsDec 16 20:31 · Ratings

Alto Neuroscience Highlights Data From Precision Psychiatry Platform At ACNP Annual Meeting; Interim Analysis For ALTO-300 Phase 2b Trial In MDD Expected Q1 2025, With Topline Results In H1 2025

BenzingaDec 11 21:14

Alto Neuroscience Announces Data Presented at the 63rd Annual Meeting of the American College of Neuropsychopharmacology

BusinesswireDec 11 21:03

Potential Catalysts and Strategic Focus: Analyzing Alto Neuroscience's Upcoming Trials and Precision Psychiatry Approach

TipRanksNov 14 15:36

Alto Neuroscience Strengthens Financial Position Amid Increased R&D

TipRanksNov 14 12:44